Our Pricing

Understanding Mounjaro Monthly Costs in the UK

Published on: June 03, 2026

If you're researching mounjaro cost per month uk, you'll find transparent pricing at Cured Pharmacy starting from £135.00 per treatment cycle. Unlike many providers, we display exact costs upfront — before your consultation — so you can budget confidently for ongoing weight management treatment.

What Determines Your Mounjaro Cost Per Month UK?

Your monthly Mounjaro cost depends primarily on your prescribed dose, which increases gradually through a structured titration schedule. Treatment typically begins at 2.5mg weekly for four weeks, then escalates to 5mg, 7.5mg, 10mg, 12.5mg, or the maximum 15mg dose based on your response and tolerability [1].

Each Mounjaro KwikPen contains four pre-filled doses for one month of weekly injections. At Cured Pharmacy, pricing starts from £124.99 per pen, with your UK prescriber determining the appropriate strength during your free clinical assessment. This transparent model means you'll know your exact monthly cost before committing to treatment.

Unlike some weight management medications that require daily administration, Mounjaro's once-weekly schedule means four injections per month — making it easier to maintain consistent treatment without daily reminders or complex dosing routines.

How Mounjaro Delivers Superior Weight Loss Results

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. This dual-action mechanism sets it apart from single-pathway treatments, activating both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously.

In the landmark SURMOUNT-1 trial, participants receiving the 15mg maintenance dose achieved an average 22.5% body weight reduction over 72 weeks — significantly outperforming placebo and exceeding results seen with semaglutide-based alternatives [1][2]. The dual receptor activation enhances satiety signals, slows gastric emptying, and improves metabolic parameters beyond weight loss alone.

Clinical data demonstrates that approximately 89% of participants on the highest Mounjaro dose achieved at least 5% weight loss, whilst 55% reached 20% or greater reduction — outcomes rarely seen with conventional weight management approaches [1].

Understanding the Titration Schedule

Mounjaro treatment follows a gradual dose escalation protocol to minimise gastrointestinal side effects whilst optimising therapeutic benefit. Your prescriber will typically start you at 2.5mg weekly for the first month, increasing by 2.5mg increments every four weeks until reaching your maintenance dose. This careful titration allows your body to adapt to the medication whilst your clinical team monitors your progress and tolerability.

Mounjaro vs Wegovy: Monthly Cost and Efficacy Comparison

Both Mounjaro and Wegovy are injectable GLP-1 receptor agonists licensed in the UK for chronic weight management, but they operate through different mechanisms and deliver distinct clinical outcomes. Wegovy contains semaglutide, a single GLP-1 receptor agonist, whilst Mounjaro's tirzepatide activates both GIP and GLP-1 receptors.

Head-to-head trial data suggests tirzepatide produces greater average weight reduction compared to semaglutide at comparable stages of treatment [2][3]. In the STEP 1 trial, semaglutide 2.4mg achieved 14.9% average weight loss over 68 weeks, whilst SURMOUNT-1 participants on tirzepatide 15mg reached 22.5% reduction over a similar timeframe [1][2].

At Cured Pharmacy, Wegovy starts from £135.00 monthly, making it a more budget-friendly option for some patients. However, your UK prescriber will recommend treatment based on your medical history, weight loss goals, and individual response rather than cost alone. Both medications require ongoing monthly prescriptions and are subject to clinical assessment.

Which Treatment Suits Your Needs?

Your prescriber considers multiple factors when recommending between Mounjaro and Wegovy: your BMI, previous weight loss attempts, concurrent medical conditions, medication tolerability, and treatment goals. Some patients respond better to one mechanism over another, whilst others prioritise different aspects such as injection frequency, side effect profile, or monthly budget. A thorough clinical consultation ensures you receive the most appropriate treatment for your circumstances.

Hidden Costs: What Other Pharmacies Don't Tell You

Many online providers advertise attractive headline prices but add consultation fees, delivery charges, or subscription commitments that inflate your actual monthly spend. At Cured Pharmacy, our pricing model is completely transparent — the amount you see is what you pay, with no hidden consultation fees or mandatory subscription lock-ins.

Some providers require you to purchase multiple months upfront or commit to ongoing subscriptions with cancellation restrictions. We believe you should have full control over your treatment journey, which is why we offer flexible monthly ordering without long-term contracts. You can pause, adjust, or discontinue treatment at any time subject to your prescriber's clinical guidance.

Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees every prescription dispensed from our GPhC-registered premises (9012511), ensuring you receive genuine UK-licensed Mounjaro pens with full regulatory compliance and pharmaceutical oversight.

Managing Side Effects to Maximise Treatment Value

The most commonly reported side effects with Mounjaro are gastrointestinal — including nausea, diarrhoea, constipation, and reduced appetite [1]. These effects typically emerge during dose escalation and diminish as your body adapts to the medication. Understanding how to manage these symptoms helps you stay on treatment and achieve optimal results.

Eating smaller, more frequent meals rather than large portions can significantly reduce nausea intensity. Avoiding high-fat, spicy, or heavily processed foods during the first few days after each injection helps minimise digestive discomfort. Staying well-hydrated and increasing dietary fibre gradually supports bowel regularity whilst your gut adapts to slower gastric emptying.

If side effects become troublesome, your prescriber may recommend staying at your current dose for an additional month before escalating, or adjusting the titration schedule to suit your individual tolerance. Never increase your dose without prescriber approval, as this increases the likelihood of discontinuation due to adverse effects.

When to Contact Your Prescriber

Whilst mild gastrointestinal symptoms are expected, certain signs warrant immediate clinical review: persistent vomiting preventing fluid intake, severe abdominal pain, signs of pancreatitis (intense upper abdominal pain radiating to the back), or symptoms of gallbladder problems. Your clinical team at Cured Pharmacy remains available throughout your treatment to address concerns and adjust your care plan as needed.

Long-Term Mounjaro Cost: Budgeting for Sustained Weight Management

Weight management with Mounjaro is not a short-term intervention — clinical trials demonstrating its efficacy followed participants for 72 weeks or longer [1]. Many patients continue treatment beyond the initial trial period to maintain their weight loss and metabolic improvements, making long-term cost planning essential.

Once you reach your maintenance dose, your monthly cost stabilises, allowing predictable budgeting. Some patients achieve their target weight and transition to a lower maintenance dose under prescriber supervision, potentially reducing ongoing costs whilst preserving clinical benefits. Others maintain their higher dose to sustain maximum metabolic effect.

Consider the broader financial context: successful weight management may reduce future healthcare costs associated with obesity-related conditions such as type 2 diabetes, cardiovascular disease, and joint problems. The National Institute for Health and Care Excellence (NICE) recognises the cost-effectiveness of GLP-1 receptor agonists in appropriate patient populations [4].

At Cured Pharmacy, we guarantee the lowest UK prices on genuine licensed medications. If you find a lower verified price elsewhere for the same product, we'll match it — ensuring you receive exceptional value throughout your weight management journey.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (Clinical guideline CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary. Weight loss outcomes depend on multiple factors including adherence to treatment, dietary modifications, and physical activity levels.